BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19017759)

  • 1. 1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: correlation with histological variants and clinical parameters.
    Dardano A; Falzoni S; Caraccio N; Polini A; Tognini S; Solini A; Berti P; Di Virgilio F; Monzani F
    J Clin Endocrinol Metab; 2009 Feb; 94(2):695-8. PubMed ID: 19017759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia.
    Thunberg U; Tobin G; Johnson A; Söderberg O; Padyukov L; Hultdin M; Klareskog L; Enblad G; Sundström C; Roos G; Rosenquist R
    Lancet; 2002 Dec; 360(9349):1935-9. PubMed ID: 12493261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible protective role of the 489C>T P2X7R polymorphism in Alzheimer's disease.
    Sanz JM; Falzoni S; Rizzo R; Cipollone F; Zuliani G; Di Virgilio F
    Exp Gerontol; 2014 Dec; 60():117-9. PubMed ID: 25456845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes.
    Cabrini G; Falzoni S; Forchap SL; Pellegatti P; Balboni A; Agostini P; Cuneo A; Castoldi G; Baricordi OR; Di Virgilio F
    J Immunol; 2005 Jul; 175(1):82-9. PubMed ID: 15972634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.
    Jendrzejewski J; Liyanarachchi S; Nagy R; Senter L; Wakely PE; Thomas A; Nabhan F; He H; Li W; Sworczak K; Ringel MD; Kirschner LS; de la Chapelle A
    Thyroid; 2016 Sep; 26(9):1276-84. PubMed ID: 27342578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression.
    Roncevic J; Djoric I; Selemetjev S; Jankovic J; Dencic TI; Bozic V; Cvejic D
    Pathology; 2019 Jan; 51(1):55-61. PubMed ID: 30497805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1513A/C polymorphism in the P2X7 receptor gene in chronic lymphocytic leukemia: absence of correlation with clinical outcome.
    Nückel H; Frey UH; Dürig J; Dührsen U; Siffert W
    Eur J Haematol; 2004 Apr; 72(4):259-63. PubMed ID: 15089763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF mutations are associated with some histological types of papillary thyroid carcinoma.
    Trovisco V; Vieira de Castro I; Soares P; Máximo V; Silva P; Magalhães J; Abrosimov A; Guiu XM; Sobrinho-Simões M
    J Pathol; 2004 Feb; 202(2):247-51. PubMed ID: 14743508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease?
    Solini A; Cuccato S; Ferrari D; Santini E; Gulinelli S; Callegari MG; Dardano A; Faviana P; Madec S; Di Virgilio F; Monzani F
    Endocrinology; 2008 Jan; 149(1):389-96. PubMed ID: 17947359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follicular variant papillary thyroid carcinoma arising in struma ovarii.
    Boutross-Tadross O; Saleh R; Asa SL
    Endocr Pathol; 2007; 18(3):182-6. PubMed ID: 18058267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma.
    Bingül İ; Vural P; Doğru-Abbasoğlu S; Çil E; Uysal M
    J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 27925342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.
    Jendrzejewski J; Liyanarachchi S; Eiterman A; Thomas A; He H; Nagy R; Senter L; Sworczak K; de la Chapelle A
    Int J Cancer; 2019 Feb; 144(3):503-512. PubMed ID: 30350351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of
    Chatzikyriakidou A; Chorti A; Papavramidis T
    In Vivo; 2019; 33(6):2281-2285. PubMed ID: 31662568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.
    Fugazzola L; Puxeddu E; Avenia N; Romei C; Cirello V; Cavaliere A; Faviana P; Mannavola D; Moretti S; Rossi S; Sculli M; Bottici V; Beck-Peccoz P; Pacini F; Pinchera A; Santeusanio F; Elisei R
    Endocr Relat Cancer; 2006 Jun; 13(2):455-64. PubMed ID: 16728573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble human leukocyte antigen-g and its insertion/deletion polymorphism in papillary thyroid carcinoma: novel potential biomarkers of disease?
    Dardano A; Rizzo R; Polini A; Stignani M; Tognini S; Pasqualetti G; Ursino S; Colato C; Ferdeghini M; Baricordi OR; Monzani F
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4080-6. PubMed ID: 22930786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of HLA DQ4-DR8 haplotype with papillary thyroid carcinomas.
    Porto T; Coelho I; Boavida J; Pereira C; Nunes JM; Mendonça D; Martins B; Sobrinho LG; Leite V
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):179-83. PubMed ID: 16430717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
    Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rs2910164 Genetic Variant of miR-146a-3p Is Associated with Increased Overall Mortality in Patients with Follicular Variant Papillary Thyroid Carcinoma.
    Kotlarek M; Kubiak A; Czetwertyńska M; Świerniak M; Gierlikowski W; Kolanowska M; Bakuła-Zalewska E; Jhiang SM; Jażdżewski K; Wójcicka A
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.